Mirae Asset Global Investments Co., Ltd. Vera Therapeutics, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $22.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,983 shares of VERA stock, worth $95,362. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,983
Previous 1,633
21.43%
Holding current value
$95,362
Previous $59,000
47.46%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding VERA
# of Institutions
183Shares Held
54.9MCall Options Held
42.2KPut Options Held
114K-
Avoro Capital Advisors LLC New York, NY4.31MShares$207 Million2.13% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.62MShares$174 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$161 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$142 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$134 Million5.61% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.3B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...